HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Khan, O. Articles by Protheroe, A. Search for Related Content PubMed PubMed Citation Articles by Khan, O. Articles by Protheroe, A.

Testis cancer

Cancer Research UK, Medical Oncology Unit, Churchill Hospital, Oxford, UK

Correspondence to:
Dr Omar Khan, Cancer Research UK, Medical Oncology Unit, Churchill Hospital, Oxford OX3 7LJ, UK; omar.khan{at}cancer.org.uk

Testis cancer is an increasing problem, especially in northern European male populations. However, survival has improved dramatically over one generation. Environmental factors may have a role in the aetiology with high oestrogen concentrations implicated. Testis cancer is subdivided between seminoma and non-seminoma. At presentation, a testicular lump is the most common finding and radical inguinal orchidectomy is recommended for most. Further multidisciplinary management is determined by histological subtype and stage and involves chemotherapy, radiotherapy and surgery, with many patients only undergoing surveillance. There is increasing emphasis on reducing toxicity of treatments in long term survivors. Treatment refractory testis cancer remains a significant challenge.

Abbreviations: AFP, -fetoprotein, AUC, area under the concentration x time curve; ß-HCG, ß-human chorionic gonadotrophin; BEP, bleomycin, etoposide and cisplatin; CT, computed tomography; EORTC, European Organisation for Research and Treatment of Cancer; EP, etoposide and cisplatin; GCT, germ cell tumour; IGCCG, International Germ Cell Cancer Collaborative Group; ITGCN, intratubular germ cell neoplasia; LDH, lactate dehydrogenase; MRC, Medical Research Council; NSGCT, non-seminomatous germ cell tumour; PET, positron emission tomography; RPLND, primary retroperitoneal lymph node dissection; SMR, standardised mortality ratio; VIP, vinblastine, etoposide and cisplatin

Keywords: testis cancer; epidemiology; aetiology; treatment; long-term toxicity

eLetters: